Inspired by nature, a new type of cryoprotectant has emerged as a safer alternativeto traditional chemicals.
The preservation of living cells and tissues is an often-underappreciated obstacle inthe clinical lab. Cryogenic temperatures attempt to address this challenge byminimizing biochemical activity within samples of interest. As the cell and genetherapy market grows, the drawbacks of cryopreservation are becoming moreapparent.
This article examines the current cryopreservation landscape within the cell andgene therapy market and explores emerging solutions to meeting supply demandsand patient safety standards.
